Hep G2 nuclear extract lysate (IL-6 stimulated (100 ng/ml)) (ab14832)
製品の概要
-
製品名
Hep G2 nuclear extract lysate (IL-6 stimulated (100 ng/ml))
HepG2 ライゼート 製品一覧 -
特記事項
Cell line: HepG2 (Human hepatocellular carcinoma).
Cells were cultured in medium supplemented with 100 ng/ml IL-6 (interleukin 6) for 15 minutes at 37°C immediately prior to harvesting.
We recommend aliquoting the extracts into single use fractions and then storing them.
製品の特性
-
Mycoplasma free
Yes -
製品の状態
Liquid -
保存方法
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles. -
バッファー
pH: 7.90
Constituents: 0.75% Potassium chloride, 0.009% PMSF, 0.01% Magnesium chloride, 0.008% DTT, 0.48% HEPES, 20% Glycerol -
Concentration information loading...
-
研究分野
-
背景
Hepatitis B virus (HBV) is the major cause of acute and chronic hepatitis, leading to progressive development of necroinflammatory changes in the liver, which can result in cirrhosis and hepatocellular carcinoma. Although the development of an effective vaccine to prevent HBV infection has shown promising results and should lead to its eventual eradication, antiviral chemotherapy remains the only effective method to prevent the progression of the disease in chronic carriers. Therefore, the development of new antiretroviral agents active against HBV is needed. HepG2 cells have an epithelial morphology and are thought to be a very useful model to study HBV virus replication via transfection. Cells are also used for cancer and apoptosis studies (in particular signalling pathway studies).
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (0)
ab14832 は論文での使用が確認できていません。